T62.0X2A Toxic effect of ingested mushrooms, intentional self-harm, initial encounter

Name of the Condition

• Toxic effect of ingested mushrooms, intentional self-harm, initial encounter

Summary

This condition describes adverse health reactions resulting from the intentional ingestion of mushrooms containing harmful substances. The effects can range from mild gastrointestinal upset to severe organ damage or neurological impairment, depending on the mushroom species and toxin type. The "initial encounter" designation indicates this is the first time the patient is receiving care for this specific toxic exposure.

Causes

Mushroom toxicity occurs when individuals consume mushrooms containing naturally occurring toxins. Common toxic compounds include amatoxins, muscarine, or psilocybin, which vary by mushroom species. Intentional self-harm involves deliberate ingestion of toxic mushrooms, often as a means of self-injury or poisoning. The specific toxin determines the nature and severity of the clinical response.

Risk Factors

• Deliberate ingestion of mushrooms for self-harm purposes.
• Access to toxic mushroom species.
• History of intentional self-harm behaviors.
• Lack of awareness about the toxicity of certain mushroom varieties.

Symptoms

• Nausea, vomiting, and abdominal pain (common early signs).
• Diarrhea, which may be severe or bloody.
• Neurological symptoms such as dizziness, confusion, or hallucinations.
• Liver or kidney dysfunction in severe cases.
• Respiratory distress or cardiovascular instability in extreme toxicity.

Diagnosis

Diagnosis relies on clinical evaluation, including symptom assessment and patient history of intentional mushroom ingestion. Laboratory tests may be used to identify specific toxins or assess organ function. Documentation should confirm the intentional nature of the exposure and the initial encounter status.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further toxin absorption. This may include gastric decontamination, supportive care, and specific antidotes if available. The approach depends on the toxin type and severity of symptoms.

Prognosis and Follow-Up

Prognosis varies based on the toxin involved, dose, and timeliness of treatment. Severe cases may require prolonged monitoring for organ damage. Follow-up care should address underlying mental health concerns and prevent recurrence.

Complications

• Severe liver or kidney failure.
• Permanent neurological damage.
• Respiratory or cardiovascular collapse.
• Long-term organ dysfunction.

Lifestyle & Prevention

• Avoid ingestion of unknown or potentially toxic mushrooms.
• Seek mental health support if experiencing self-harm thoughts.
• Educate on mushroom toxicity and safe foraging practices.
• Store mushrooms safely to prevent accidental or intentional misuse.

When to Seek Professional Help

Seek immediate medical attention if intentional mushroom ingestion is suspected, especially with symptoms like severe vomiting, confusion, or difficulty breathing. Prompt care improves outcomes.

Tips for Medical Coders

Document the intentional self-harm context and initial encounter status clearly. Ensure the code T62.0X2A is used when the exposure is intentional and this is the first encounter for the toxic effect. Verify that clinical documentation supports the intentional nature of the ingestion and the initial encounter designation.